On the stock market since 2017, it operates in the world of health and science. It has 16 employees. Now — the numbers.
This is an established company with proven profits.
Red columns mark years that ended in a loss.
If every debt were paid off today, $33.6M would still be left in the vault — a solid cushion for hard times.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Profit per Sale: The profit kept from each sale is thin.
An investor who bought at the very peak is down 97% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
There is $33.6M in the vault; even if every debt were paid off, $33.6M would remain.
It met or beat analyst expectations in 6 of the last 7 quarters — consistency is a promise kept.
The stock sits at $0.16. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
Since the drop from its peak, buyer appetite hasn’t come back. Council score: 0/10.
As the slice kept from each sale thins out, so does the profit. Council score: 3/10.
On our five-subject report card, MDNA sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: MDNA is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.